The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials

References

• Schwartz N, Green MS, Yefet E, et al. Modifiable risk factors for gestational diabetes recurrence. Endocrine. 2016;54:714–722.
   PubMed Web of Science ®Google Scholar
• Spaight C, Gross J, Horsch A, et al. Gestational diabetes mellitus. Endocr Dev. 2016;31:163–178.
   PubMedGoogle Scholar
• Proceedings of the 4th International workshop-conference on gestational diabetes mellitus. Chicago, Illinois 14–16 March 1997. Diabetes Care. 1998;21:B1–B167.
   Google Scholar
• Domínguez-Vigo P, Álvarez-Silvares E, Alves-Pérez MT, et al. Incidence and clinical risk factors for the development of diabetes mellitus in women with previous gestational diabetes. Ginecol Obstet Mex. 2016;84:228–242.
   PubMedGoogle Scholar
• Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to Type 2 diabetes: a global perspective. Curr Diab Rep. 2016;16:7.
   PubMed Web of Science ®Google Scholar
• Ali FM, Farah N, O’Dwyer V, et al. The impact of new national guidelines on screening for gestational diabetes mellitus. Ir Med J. 2013;106:57–59.
   PubMedGoogle Scholar
• D’Anna R, Scilipoti A, Giordano D, et al. Myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care. 2013;36:854–857.
   PubMed Web of Science ®Google Scholar
• Eggleston EM, LeCates RF, Zhang F, et al. Variation in postpartum glycemic screening in women with a history of gestational diabetes mellitus. Obstet Gynecol. 2016;128:159–167.
   PubMed Web of Science ®Google Scholar
• Olsen SF, Houshmand-Oeregaard A, Granström C, et al. Diagnosing gestational diabetes mellitus in the Danish National Birth Cohort. Acta Obstet Gynecol Scand. 2017;96:563–569.
   PubMed Web of Science ®Google Scholar
• Michell RH. The multiplying roles of inositol lipids and phosphates in cell control processes. Essays Biochem. 1997;32:31–47.
   PubMed Web of Science ®Google Scholar
• Saltiel AR. Second messengers of insulin action. Diabetes Care. 1990;13:244–256.
   PubMed Web of Science ®Google Scholar
• Muscogiuri G, Palomba S, Laganà AS, et al. Inositols in the treatment of insulin-mediated diseases. Int J Endocrinol. 2016;2016:3058393.
   PubMed Web of Science ®Google Scholar
• Pintaudi B, Di Vieste G, Bonomo M. The effectiveness of myo-inositol and D-chiro inositol treatment in Type 2 diabetes. Int J Endocrinol. 2016;2016:9132052.
   PubMed Web of Science ®Google Scholar
• Plows JF, Budin F, Andersson RA, et al. The Effects of myo-inositol and B and D vitamin supplementation in the db/+ mouse model of gestational diabetes mellitus. Nutrients. 2017;9(2):141.
   PubMed Web of Science ®Google Scholar
• Corrado F, D’Anna R, Di Vieste G, et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011;28:972–975.
   PubMed Web of Science ®Google Scholar
• Costabile L, Unfer V. Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from a peculiar case. Eur Rev Med Pharmacol Sci. 2017;21:73–76.
   PubMed Web of Science ®Google Scholar
• D’Anna R, Di Benedetto A, Scilipoti A, et al. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol. 2015;126:310–315.
   PubMed Web of Science ®Google Scholar
• D’Anna R, Di Benedetto V, Rizzo P, et al. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol. 2012;28:440–442.
   PubMed Web of Science ®Google Scholar
• Farren M, Daly N, McKeating A, et al. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes Care. 2017;40:759–763.
   PubMed Web of Science ®Google Scholar
• Matarrelli B, Vitacolonna E, D’Angelo M, et al. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013;26:967–972.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–1012.
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
   PubMedGoogle Scholar
• Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001;135:982–989.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.
   PubMed Web of Science ®Google Scholar
• Santamaria A, Di Benedetto A, Petrella E, et al. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med. 2016;29:3234–3237.
   PubMed Web of Science ®Google Scholar
• Garrison A. Screening, diagnosis, and management of gestational diabetes mellitus. Am Fam Phys. 2015;91:460–467.
   PubMed Web of Science ®Google Scholar
• Schwartz N, Nachum Z, Green MS. The prevalence of gestational diabetes mellitus recurrence – effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol. 2015;213:310–317.
   PubMed Web of Science ®Google Scholar
• Arnold DL, Enquobahrie DA, Qiu C, et al. Early pregnancy maternal vitamin D concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2015;29:200–210.
   PubMed Web of Science ®Google Scholar
• Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008;31:1668–1669.
   PubMed Web of Science ®Google Scholar
• Zheng X, Liu Z, Zhang Y, et al. Relationship between myo-inositol supplementary and gestational diabetes mellitus: a meta-analysis. Medicine. 2015;94:e1604.
   PubMed Web of Science ®Google Scholar
• Crawford TJ, Crowther CA, Alsweiler J, et al. Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database Syst Rev. 2015;(12):CD011507. doi: 10.1002/14651858.CD011507.pub2
   PubMedGoogle Scholar
• Nordio M, Proietti E. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. Eur Rev Med Pharmacol Sci. 2012;16:575–581.
   PubMed Web of Science ®Google Scholar
• Coustan DR. Can a dietary supplement prevent gestational diabetes mellitus? Diabetes Care. 2013;36:777–779.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Z-L, Liu B, et al. Pregnancy outcome of overweight and obese Chinese women with gestational diabetes. J Obstet Gynaecol. 2014;34:662–665.
   PubMedGoogle Scholar
• Pintaudi B, Di Vieste G, Corrado F, et al. Improvement of selective screening strategy for gestational diabetes through a more accurate definition of high-risk groups. Eur J Endocrinol. 2014;170:87–93.
   PubMed Web of Science ®Google Scholar
• Hadden DR, McLaughlin C. Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonat Med. 2009;14:66–71.
   PubMed Web of Science ®Google Scholar
• Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991;165:1667–1672.
   PubMed Web of Science ®Google Scholar